Cme Group INC Form 4 insider transactions

CME Group's President and CFO, Lynne Fitzpatrick, reported the vesting of performance shares and subsequent tax-related share surrenders.

CME Group's Chief Accounting Officer, Jack J. Tobin, reported the vesting of performance shares and subsequent tax-related share disposition.

CME Group's Chief Information Officer, Sunil Cutinho, reported the vesting of 8,256 performance shares and the disposition of 3,658 shares for tax obligations.

CME Group's MD Chief Accounting Officer, Jack J. Tobin, reported gifting 105 shares of Common Stock Class A.

CME Group's Chief Transformation Officer, Ken Vroman, reported the sale of 5,160 shares of Class A common stock at an average price of $309 under a pre-arranged plan.

CME Group Inc. Director Bryan T. Durkin sold 4,200 shares of Class A common stock for approximately $309.65 per share on February 23, 2026, under a Rule 10b5-1 plan.

CME Group Inc. Director Dennis Suskind reported a future sale of 748 shares of Class A Common Stock at $300 per share, effective February 6, 2026.

CME Group Inc. Director William R. Shepard increased his beneficial ownership of Class A Common Stock through a dividend reinvestment plan on December 30, 2025.

CME Group Chairman and CEO Terrence A. Duffy disposed of 10,210 shares of Common Stock Class A on December 31, 2025, to cover tax withholding obligations related to restricted stock vesting.

CME Group Chairman and CEO Terrence A. Duffy sold 25,000 shares of Class A common stock for approximately $6.73 million through a pre-arranged trading plan.

Derek Sammann, Senior Managing Director and Global Head of Commodities Markets at CME Group Inc., reported the sale of 7,200 Class A common shares for approximately $1.98 million under a Rule 10b5-1 plan.

CME Group's Sr MD & Chief HR Officer, Hilda Harris Piell, reported gifting 973 shares of Common Stock Class A to her donor advised fund.

CME Group Inc. Director Harold Ford Jr. sold 1,000 shares of Class A common stock on November 3, 2025, for a weighted average price of $263.53.

CME Group Director William R. Shepard acquired additional Class A Common Stock through a dividend reinvestment plan on September 25, 2025.

Jonathan L. Marcus, CME Group's Senior Managing Director and General Counsel, sold 392 shares of Class A Common Stock for $262 per share pursuant to a pre-arranged Rule 10b5-1 plan.

CME Group's Chief Information Officer, Sunil Cutinho, reported changes in his beneficial ownership of Class A Common Stock, including acquisitions and dispositions related to restricted stock vesting and tax obligations.

Julie Winkler, CME Group's Sr MD Chief Commercial Officer, reported the acquisition and disposition of Common Stock Class A shares related to restricted stock vesting and tax obligations.

CME Group's Chief Transformation Officer, Ken Vroman, reported the acquisition and disposition of Common Stock Class A shares related to restricted stock vesting and tax obligations.

Jonathan L. Marcus, CME Group's Sr MD General Counsel, reported acquisitions, sales, and tax-related dispositions of company stock.

CME Group's Chief Operating Officer, Suzanne Sprague, reported the acquisition of 3,044 shares and disposition of 964 shares for tax obligations related to restricted stock vesting.

CME Group's President and CFO, Lynne Fitzpatrick, reported routine acquisitions and dispositions of common stock tied to restricted stock vesting and tax obligations.

Jack J. Tobin, CME Group's MD Chief Accounting Officer, reported the vesting of restricted stock and subsequent share dispositions to cover tax obligations.

Michael G. Dennis, CME Group's Global Head of Fixed Income, reported a planned acquisition of 2,608 shares and a subsequent disposition of 289 shares for tax obligations in September 2025.

CME Group Senior Managing Director Timothy McCourt reported stock acquisitions and dispositions related to restricted stock vesting and tax obligations.

CME Group Senior Managing Director Derek Sammann reported recent acquisitions and tax-related dispositions of company stock.

CME Group's Chairman and CEO, Terrence A. Duffy, acquired 23,180 shares of Common Stock Class A at a price of $258.83 per share.

CME Group's Sr MD & Chief HR Officer, Hilda Harris Piell, reported recent stock transactions involving the vesting of restricted stock and subsequent tax withholdings, resulting in a net increase in her beneficial ownership.

CME Group's Chief Information Officer, Sunil Cutinho, sold 11,896 shares of Class A common stock in pre-planned transactions.

CME Group Inc. Director Patrick W. Maloney has acquired 532 shares of Common Stock Class A at a price of $273.03 per share, increasing his direct beneficial ownership to 4,098 shares.

CME Group Inc. Director Harold Eugene Ford Jr. acquired 532 shares of Common Stock Class A at a price of $273.03 per share on June 25, 2025, as part of the company's Director Stock Plan.